-
1
-
-
76749170024
-
Recombinant protein expression in Escherichia coli
-
Baneyx F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 461 (1999) 45-61
-
(1999)
Curr. Opin. Biotechnol.
, vol.461
, pp. 45-61
-
-
Baneyx, F.1
-
2
-
-
0035313153
-
Advances in Escherichia coli production of therapeutic proteins
-
Swartz J.R. Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 12 (2001) 195-201
-
(2001)
Curr. Opin. Biotechnol.
, vol.12
, pp. 195-201
-
-
Swartz, J.R.1
-
3
-
-
0029989229
-
Expression of correctly folded proteins in Escherichia coli
-
Georgiou G., and Valax P. Expression of correctly folded proteins in Escherichia coli. Curr. Opin. Biotechnol. 7 (1996) 190-197
-
(1996)
Curr. Opin. Biotechnol.
, vol.7
, pp. 190-197
-
-
Georgiou, G.1
Valax, P.2
-
4
-
-
0029828233
-
Strategies for achieving high-level expression of genes in Escherichia coli
-
Makrides S.C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60 (1996) 512-538
-
(1996)
Microbiol. Rev.
, vol.60
, pp. 512-538
-
-
Makrides, S.C.1
-
5
-
-
0020816967
-
Immunocytochemical demonstration of human proinsulin chimeric polypeptide within cytoplasmic inclusion bodies of Escherichia coli
-
Paul D.C., Van Frank R.M., Muth L.M., Ross J.W., and Williams D.C. Immunocytochemical demonstration of human proinsulin chimeric polypeptide within cytoplasmic inclusion bodies of Escherichia coli. Eur. J. Cell Biol. 31 (1983) 171-174
-
(1983)
Eur. J. Cell Biol.
, vol.31
, pp. 171-174
-
-
Paul, D.C.1
Van Frank, R.M.2
Muth, L.M.3
Ross, J.W.4
Williams, D.C.5
-
6
-
-
0023050642
-
The purification of eukaryotic polypeptides synthesised in Escherichia coli
-
Marston F.A.O. The purification of eukaryotic polypeptides synthesised in Escherichia coli. Biochem. J. 240 (1986) 1-12
-
(1986)
Biochem. J.
, vol.240
, pp. 1-12
-
-
Marston, F.A.O.1
-
7
-
-
0024017415
-
Formation of recombinant protein inclusion bodies in Escherichia coli
-
Kane J.F., and Hartley D.L. Formation of recombinant protein inclusion bodies in Escherichia coli. Trends Biotechnol. 6 (1988) 95-101
-
(1988)
Trends Biotechnol.
, vol.6
, pp. 95-101
-
-
Kane, J.F.1
Hartley, D.L.2
-
8
-
-
0030204090
-
Protein folding in vivo and renaturation of recombinant proteins from inclusion bodies
-
Guise A.D., West S.M., and Chaudhuri J.B. Protein folding in vivo and renaturation of recombinant proteins from inclusion bodies. Mol. Biotechnol. 6 (1996) 53-64
-
(1996)
Mol. Biotechnol.
, vol.6
, pp. 53-64
-
-
Guise, A.D.1
West, S.M.2
Chaudhuri, J.B.3
-
9
-
-
19644389665
-
Solubilization and refolding of bacterial inclusion body proteins
-
Singh S.M., and Panda A.K. Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng. 99 (2005) 303-310
-
(2005)
J. Biosci. Bioeng.
, vol.99
, pp. 303-310
-
-
Singh, S.M.1
Panda, A.K.2
-
10
-
-
0031259833
-
Affinity fusion strategies for detection, purification and immobilisation of recombinant protein
-
Nilsson J., Stahl S., Lundeburg J., Uhlen M., and Nygren P.-A. Affinity fusion strategies for detection, purification and immobilisation of recombinant protein. Protein Expr. Purif. 11 (1997) 1-6
-
(1997)
Protein Expr. Purif.
, vol.11
, pp. 1-6
-
-
Nilsson, J.1
Stahl, S.2
Lundeburg, J.3
Uhlen, M.4
Nygren, P.-A.5
-
11
-
-
0028825817
-
Gene fusion expression systems in Escherichia coli
-
LaVallie E.R., and McCoy J.M. Gene fusion expression systems in Escherichia coli. Curr. Opin. Biotechnol. 6 (1995) 501-506
-
(1995)
Curr. Opin. Biotechnol.
, vol.6
, pp. 501-506
-
-
LaVallie, E.R.1
McCoy, J.M.2
-
12
-
-
0030174333
-
A general bacterial expression system for functional analysis of cDNA-encoded proteins
-
Larsson M., Brundell E., Nordfors L., Hoog C., Uhlen M., and Stahl S. A general bacterial expression system for functional analysis of cDNA-encoded proteins. Protein Expr. Purif. 7 (1996) 447-457
-
(1996)
Protein Expr. Purif.
, vol.7
, pp. 447-457
-
-
Larsson, M.1
Brundell, E.2
Nordfors, L.3
Hoog, C.4
Uhlen, M.5
Stahl, S.6
-
13
-
-
33746744319
-
Enhancement of soluble protein expression through the use of fusion tags
-
Esposito D., and Chatterjee D.K. Enhancement of soluble protein expression through the use of fusion tags. Curr. Opin. Biotechnol. 17 (2006) 353-358
-
(2006)
Curr. Opin. Biotechnol.
, vol.17
, pp. 353-358
-
-
Esposito, D.1
Chatterjee, D.K.2
-
14
-
-
0033607265
-
Purification, characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif
-
Ton-That H., Liu G., Mazmanian S.K., Faull K.F., and Schneewind O. Purification, characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif. Proc. Natl. Acad. Sci. USA 96 (1999) 12424-12429
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 12424-12429
-
-
Ton-That, H.1
Liu, G.2
Mazmanian, S.K.3
Faull, K.F.4
Schneewind, O.5
-
15
-
-
0035932982
-
Structure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureus
-
Ilangovan U., Ton-That H., Iwahara J., Schneewind O., and Clubb R.T. Structure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 98 (2001) 6056-6061
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 6056-6061
-
-
Ilangovan, U.1
Ton-That, H.2
Iwahara, J.3
Schneewind, O.4
Clubb, R.T.5
-
16
-
-
0037106334
-
Irreversible inhibition of the bacterial cysteine protease-transpeptidase sortase (SrtA) by substrate-derived affinity labels
-
Scott C.J., McDowell A., Martin S.L., Lynas J.F., Vandenbroeck K., and Walker B. Irreversible inhibition of the bacterial cysteine protease-transpeptidase sortase (SrtA) by substrate-derived affinity labels. Biochem. J. 366 (2002) 953-958
-
(2002)
Biochem. J.
, vol.366
, pp. 953-958
-
-
Scott, C.J.1
McDowell, A.2
Martin, S.L.3
Lynas, J.F.4
Vandenbroeck, K.5
Walker, B.6
-
17
-
-
0141791245
-
Kinetic mechanism of Staphylococcus aureus sortase SrtA
-
Huang X., Aulabaugh A., Ding W., Kapoor B., Alksne L., Tabei K., and Ellestad G. Kinetic mechanism of Staphylococcus aureus sortase SrtA. Biochemistry 42 (2003) 11307-11315
-
(2003)
Biochemistry
, vol.42
, pp. 11307-11315
-
-
Huang, X.1
Aulabaugh, A.2
Ding, W.3
Kapoor, B.4
Alksne, L.5
Tabei, K.6
Ellestad, G.7
-
18
-
-
0033059496
-
The murine homologue of the human NKp46 a triggering receptor involved in the induction of natural cytotoxicity
-
Biassoni R., Pessino A., Bottino C., Pende D., Moretta L., and Moretta A. The murine homologue of the human NKp46 a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 29 (1999) 1014-1020
-
(1999)
Eur. J. Immunol.
, vol.29
, pp. 1014-1020
-
-
Biassoni, R.1
Pessino, A.2
Bottino, C.3
Pende, D.4
Moretta, L.5
Moretta, A.6
-
19
-
-
44649088312
-
-
E. Yamada, D.W. McVicar, Paired receptor systems of the innate immune 398 system, Curr. Protoc. Immunol. 23 (2008) 1-15 (Chapter 1: Appendix 1X).
-
E. Yamada, D.W. McVicar, Paired receptor systems of the innate immune 398 system, Curr. Protoc. Immunol. 23 (2008) 1-15 (Chapter 1: Appendix 1X).
-
-
-
-
20
-
-
34249106050
-
Inhibition of cathepsin L-like proteases by cathepsin V propeptide
-
Burden R.E., Snoddy P., Jefferies C.A., Walker B., and Scott C.J. Inhibition of cathepsin L-like proteases by cathepsin V propeptide. Biol. Chem. 388 (2007) 541-545
-
(2007)
Biol. Chem.
, vol.388
, pp. 541-545
-
-
Burden, R.E.1
Snoddy, P.2
Jefferies, C.A.3
Walker, B.4
Scott, C.J.5
-
21
-
-
41649103656
-
Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment
-
Burden R.E., Snoddy P., Buick R.J., Johnston J.A., Walker B., and Scott C.J. Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment. Mol. Cancer Ther. 7 (2008) 538-547
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 538-547
-
-
Burden, R.E.1
Snoddy, P.2
Buick, R.J.3
Johnston, J.A.4
Walker, B.5
Scott, C.J.6
-
23
-
-
65349147691
-
Siglecs as targets for therapy in immune-cell-mediated disease
-
O'Reilly M.K., and Paulson J.C. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol. Sci. 30 (2009) 240-248
-
(2009)
Trends Pharmacol. Sci.
, vol.30
, pp. 240-248
-
-
O'Reilly, M.K.1
Paulson, J.C.2
-
24
-
-
0242298171
-
Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias
-
Virgo P., Denning-Kendall P.A., Erickson-Miller C.L., Singha S., Evely R., Hows J.M., and Freeman S.D. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias. Br. J. Haematol. 123 (2003) 420-430
-
(2003)
Br. J. Haematol.
, vol.123
, pp. 420-430
-
-
Virgo, P.1
Denning-Kendall, P.A.2
Erickson-Miller, C.L.3
Singha, S.4
Evely, R.5
Hows, J.M.6
Freeman, S.D.7
-
26
-
-
3543063548
-
A self-cleavable sortase fusion for one-step purification of free recombinant proteins
-
Mao H. A self-cleavable sortase fusion for one-step purification of free recombinant proteins. Protein Expr. Purif. 37 (2004) 253-263
-
(2004)
Protein Expr. Purif.
, vol.37
, pp. 253-263
-
-
Mao, H.1
|